AwardedSuppliesEuropeanOpen

Measles, Mumps and Rubella vaccines 2023

Type
Supplies
33651600
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The Rijksinstituut voor Volksgezondheid en Milieu (RIVM) is seeking suppliers for the supply of MMR vaccines (Measles, Mumps and Rubella) for the Dutch immunization programme. The procurement is an open, public procedure without a CPV code. Suppliers must comply with EU standards for vaccine production, including GMP certification, CE marking, and approval by the European Medicines Agency (EMA). The contract duration is typically several years with fixed delivery schedules, and the supplier is expected to have a robust logistics chain to ensure the cold chain. The RIVM expects transparent pricing, clear quality and safety documentation, and a proven track record in supplying vaccines to national health organisations. Suppliers must also comply with Dutch laws and regulations regarding medicinal products and must not have any conflicts with the RIVM.

Supplies · Open · European procedure

European
Contract type
Supplies
Open
Estimated value
Estimate not published
Submission deadline
Ongoing
12:00
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Bilthoven
CharacteristicsCPV 33SuppliesEU tenderMMRvaccinesRIVM

01What is being requested

The Rijksinstituut voor Volksgezondheid en Milieu (RIVM) is seeking suppliers for the supply of MMR vaccines (Measles, Mumps and Rubella) for the Dutch immunization programme. The procurement is an open, public procedure without a CPV code. Suppliers must comply with EU standards for vaccine production, including GMP certification, CE marking, and approval by the European Medicines Agency (EMA). The contract duration is typically several years with fixed delivery schedules, and the supplier is expected to have a robust logistics chain to ensure the cold chain. The RIVM expects transparent pricing, clear quality and safety documentation, and a proven track record in supplying vaccines to national health organisations. Suppliers must also comply with Dutch laws and regulations regarding medicinal products and must not have any conflicts with the RIVM.

The objective of this ITT is to fulfil the need for MMR Vaccines for the benefit of the Dutch Immunization programme.

33651600Supplies
1Lot 1€1

02Outcome

Awarded

Merck Sharp & Dohme B.V.

Bidders
1

03Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

04Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

05Bidders in this segment

#Likely bidderFitWins
1GlaxoSmithKline B.V.SME71
2Johnson & Johnson Medical B.V.SME6816×
3Mediost B.V.SME6814×
4Siemens Healthineers Nederland B.V.SME6813×
5Merck Sharp & Dohme B.V.SME67
6King Nederland B.V.SME6510×

06Legal themes that may be relevant here

07Frequently asked questions

What is the objective of this contract?
The objective of this contract is to fulfil the need for MMR vaccines (Measles, Mumps and Rubella) for the benefit of the Dutch immunization programme.
What is the nature of the requested supplies?
The contract concerns the supply of MMR vaccines for the Dutch immunization programme.

Automatically compiled from the official tender data and documents.

08Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528